In this issue:
Mortality risks associated with alopecia areata
Topical calcineurin inhibitors for vitiligo
AD in hospitalised adults: childhoodvs. late-onset
Cyclosporine for moderate-tosevere alopecia areata
Registry of early-stage mycosis fungoides
Acne and obesity in adolescents
Dupilumab vs. cyclosporin for moderate-to-severe AD in adults
Novel therapeutic approaches to xeroderma pigmentosum
MVK mutations in DSAP
Characteristics, risk factors and treatment of livedoid vasculopathy
Please login below to download this issue (PDF)